"Peru Pharmaceuticals & Healthcare Report Q1 2016" now available at Fast Market Research

Although Peru has still to overcome several institutional shortcomings in public services, its promising economic outlook and its government's commitment to increased investment in the healthcare sector will be factors contributing to the improvement of Peru's pharmaceutical business environment. We believe that, over the next decade, drugmakers and medical device firms will enjoy revenue growth in the country, in the light of efforts to achieve greater health coverage and improved health indicators .

Headline Expenditure Projections

Pharmaceuticals: PEN4.67bn (USD1.65bn) in 2014 to PEN4.98bn (USD1.56bn) in 2015; +6.7% in local currency terms and -4.9% in US dollar terms. Forecast unchanged from previous quarter in local currency, downgraded in US dollars due to revised exchange rate expectations .
Healthcare: PEN31.6bn (USD11.14bn) in 2014 to PEN33.9bn (USD10.65bn) in 2015; +7.2% in local currency terms and -4.5% in US dollar terms. Forecast has been revised downward from Q 415 based on historic data.

Full Report Details at
- http://www.fastmr.com/prod/1082783_peru_pharmaceuticals.aspx?afid=301

Risk/Reward Index

In BMI's Risk/Reward Index (RRI) for Q1 2016, Peru has maintained its position as ninth out of the 19 markets surveyed in the Americas matrix. Peru's Reward scores are viewed as being less favourable than the regional averages, while its risk scores are slightly above average. A small market size and a deficient intellectual property environment are some of the major drawbacks to involvement in Peru by foreign companies. Nevertheless, Peru is still seen as being able to offer longer-term benefits to foreign investors, on account of the expected healthcare market development and economic growth.

The Peru Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Peru Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Peru pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Peru, to test other views - a key input for successful budgeting and strategic business planning in the Peruvian pharmaceutical and healthcare market.
* Target business opportunities and risks in the Peruvian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Peru.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Saudi Arabia Pharmaceuticals & Healthcare Report Q1 2016
- Kenya Pharmaceuticals & Healthcare Report Q1 2016
- Ukraine Pharmaceuticals & Healthcare Report Q1 2016
- Thailand Pharmaceuticals & Healthcare Report Q1 2016
- Oman Pharmaceuticals & Healthcare Report Q1 2016